Restenosis: Clinical Trials

18 trials for Restenosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 3 unknown, 2 recruiting, 1 terminated. 18 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable18Completed 11, Unknown 3, Recruiting 2, Terminated 1, Withdrawn 1

Follow Restenosis: new trials by email Literature Review of Restenosis trials Research Report on Restenosis

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravascular Ultrasound for Peripheral Artery Disease Revascularization
IVUS-guided strategy - Peripheral Arterial Disease(PAD), Chronic Limb Threatening Ischemia
Not applicableRecruitingHamilton Health Sciences Corporation7722025-12-052026-09-18
Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions
Intravascular lithotripsy, Balloon - Coronary Angioplasty, Restenosis
Not applicableRecruitingUniversity Hospital, Clermont-Ferrand802025-10-222026-01-05
Long-term Follow-up NIRS-IVUS Imaging of Pre-existing Carotid Stents
Near-infrared spectroscopy and intravascular ultrasound (NIRS-IVUS) - Carotid Atherosclerosis, Carotid Artery Stenting
Not applicableCompletedUniversity Hospital, Motol522017-07-152020-04-29
Search for Restenosis Markers in Lower Limb Arteritis
To look for serum microRNA profiles associated with restenosis - Restenosis, Lower Limb Arteritis
Not applicableWithdrawnCentre Hospitalier Universitaire, Amiens2017-06-202017-07-21
Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
SeQuent Please OTW, Eluvia Vascular Stent System, Nitinol stent - Stenosis, Occlusion
Not applicableCompletedInnoRa GmbH2242017-03-302024-02-15
Local Paclitaxel or Balloon Angioplasty Below the Knee
SequentPlease OTW paclitaxel coated balloon catheter, conventional uncoated balloon for BTK endovascular therapy - Stenosis, Occlusion
Not applicableUnknownProf. Dr. med. Gunnar Tepe1202016-12-152017-05-11
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)
Covera(TM) Vascular Covered Stent - Stenosis, Restenosis
Not applicableCompletedC. R. Bard1102016-07-012020-04-14
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Covera Vascular Covered Stent following PTA, Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon - Stenosis, Restenosis
Not applicableCompletedC. R. Bard2802016-06-012021-12-21
Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis
Lutonix DCB, Standard Uncoated Balloon Angioplasty Catheter - Femoral Artery Stenosis, Femoral Artery Occlusion
Not applicableCompletedC. R. Bard822014-03-012019-04-11
OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA
TAXUS™ Element long stent - Coronary Heart Disease, Diabetes
Not applicableCompletedCentre Chirurgical Marie Lannelongue3002012-10-012020-01-23
JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions
JetStream Navitus - Restenosis, Peripheral Vascular Disease
Not applicableCompletedMidwest Cardiovascular Research Foundation292012-10-012020-03-03
Treatment of Coronary In-Stent Restenosis
paclitaxel-coated balloon catheter with Iopromide coating, drug eluting stent with everolimus, seal-wing paclitaxel-eluting balloon catheter - Restenosis
Not applicableCompletedUniversity Hospital Ostrava1992012-01-012022-12-08
Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention
Paclitaxel, Placebo - Restenosis, Peripheral Arterial Disease
Not applicableUnknownMidwest Cardiovascular Research Foundation1002012-01-012012-05-15
Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions
Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems - Restenosis
Not applicableUnknownHerz-Zentrums Bad Krozingen502011-04-012011-02-21
FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis
Fluency Plus Endovascular Stent Graft, Percutaneous Transluminal Angioplasty only - Restenosis
Not applicableCompletedC. R. Bard2752010-12-012017-01-09
Tight Glycemic Control During Angioplasty Revascularization Reduces Coronary Stent Restenosis
Insulin - Restenosis, Tight Glycemic Control
Not applicableCompletedUniversity of Campania Luigi Vanvitelli2002009-12-012011-12-21
SEDUCE OCT Study in Coronary Artery rEstenosis:an Optical Coherence Tomography (OCT) Study
Sequent Please Paclitaxel eluting balloon, Xience V everolimus eluting stent - Restenosis
Not applicableCompletedUniversitaire Ziekenhuizen KU Leuven502009-05-012023-01-27
Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis
Spectranetics Laser with adjunct PTA and Gore VIABAHN Endoprosthesis with Heparin Bioactive Surface - Restenosis
Not applicableTerminatedVIVA Physicians272007-11-012014-06-04

Narrower conditions

Constriction, Pathologic (4)  ·  Bites and Stings (2)  ·  Chronic Limb-Threatening Ischemia (2)  ·  Coronary Artery Disease (2)  ·  Kidney Failure, Chronic (2)  ·  Peripheral Arterial Disease (2)  ·  Arteriovenous Fistula (1)  ·  Carotid Artery Diseases (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus (1)  ·  Hyperglycemia (1)  ·  Insulin Resistance (1)  ·  Peripheral Vascular Diseases (1)  ·  Plaque, Atherosclerotic (1)

Broader conditions

Cardiovascular Diseases (9)  ·  Vascular Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Arterial Occlusive Diseases (5)  ·  Arteriosclerosis (5)  ·  Pathological Conditions, Anatomical (5)  ·  Chronic Disease (4)  ·  Disease Attributes (4)  ·  Pathologic Processes (4)  ·  Atherosclerosis (3)  ·  Heart Diseases (3)  ·  Myocardial Ischemia (3)  ·  Peripheral Vascular Diseases (3)  ·  Chemically-Induced Disorders (2)  ·  Coronary Disease (2)

Interventions

Angioplasty (1)  ·  Drug-Eluting Stents (1)  ·  Insulin (1)  ·  Paclitaxel (1)  ·  Spectroscopy, Near-Infrared (1)

Sponsors

C. R. Bard (4)  ·  Midwest Cardiovascular Research Foundation (2)  ·  Centre Chirurgical Marie Lannelongue (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Herz-Zentrums Bad Krozingen (1)  ·  InnoRa GmbH (1)  ·  Prof. Dr. med. Gunnar Tepe (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University Hospital Ostrava (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University Hospital, Motol (1)  ·  University of Campania Luigi Vanvitelli (1)  ·  VIVA Physicians (1)

Countries

United States (7)  ·  Austria (3)  ·  France (3)  ·  Germany (3)  ·  Belgium (2)  ·  Czechia (2)  ·  Australia (1)  ·  Canada (1)  ·  Italy (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Switzerland (1)

Top investigators

Bart Dolmatch, M.D. (2)  ·  Gunnar Tepe, MD (2)  ·  Abigail Falk, M.D. (1)  ·  Alexander Yevzlin, MD (1)  ·  Carlos Mena, MD (1)  ·  Eric J Dippel, MD (1)  ·  Ivan Maya, MD (1)  ·  Leos Pleva, M.D. (1)  ·  Nicolas W Shammas, MD, MS (1)  ·  Raffaele Marfella, MD, PhD (1)  ·  Tom Adriaenssens, MD (1)  ·  Tony Das, MD (1)  ·  Walter Desmet, MD, PhD (1)

Results publications

PMID 14993129, PMID 15172398, PMID 19228612, PMID 22639289, PMID 23876463, PMID 25138182, PMID 26921281, PMID 27069104, PMID 28651572, PMID 30019843, PMID 35070788, PMID 36990214, PMID 42573020